Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2916 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bayer and Onyx cancer drug wins approval in China

The approval was based on two international Phase III double-blind, placebo-controlled trials that evaluated more than 800 patients who received no prior systemic therapy. Nexavar targets both the

GSK and HSCI partner in stem cell research

GlaxoSmithKline’s (GSK’s) investment is expected to support research at Harvard University and in at least four Harvard-affiliated hospitals in the areas of neuroscience, heart disease, cancer, diabetes, musculoskeletal

Osiris Therapeutics names new CFO

Mr Hunt will report directly to Randal Mills, president and CEO. Additionally, Philip Jacoby, Jr, the company’s controller and interim CFO, has been promoted to the position of

Ranbaxy introduces Omeprazole 40mg capsules

Ranbaxy’s Omeprazole 40mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. Jim Meehan, vice president of sales and distribution at Ranbaxy Pharmaceuticals,